Hamilton Thorne to Host Investor Webcast on May 1, 2018

BEVERLY, Mass. and TORONTO, April 26, 2018 -- Hamilton Thorne Ltd. (TSX-V:HTL), a leading world-wide provider of precision instruments, consumables, software and services to the Assisted Reproductive Technologies (ART) and developmental biology research markets, today announced that it will host a webcast investor presentation on Tuesday, May 1st at 11:00 AM ET.

During the webcast, David Wolf, CEO will provide an introductory presentation that will cover key areas of Hamilton Thorne’s business.  Topics will cover: products and services, the current state of the industry, expected market trends, recent results, growth strategy and future objectives.  During parts of the presentation, investors will have an opportunity to ask relevant questions and interact with management.

To listen to the live webcast or to ask questions during the live event, please pre-register at the following link: https://event.webcasts.com/starthere.jsp?ei=1189984&tp_key=78d2cb4865.  An archived version of the webcast and presentation will be available on the Company's website at www.hamiltonthorne.com following the event.

About Hamilton Thorne Ltd. (www.hamiltonthorne.com)

Hamilton Thorne is a leading global provider of precision instruments, consumables, software and services that reduce cost, increase productivity, improve results and enable breakthroughs in Assisted Reproductive Technologies (ART) and developmental biology research markets. Hamilton Thorne markets its products and services under the Hamilton Thorne, Gynemed and Embryotech Laboratories brands, through its growing sales force and distributors worldwide. Hamilton Thorne’s customer base consists of fertility clinics, university research centers, animal breeding facilities, pharmaceutical companies, biotechnology companies, and other commercial and academic research establishments.

Neither the Toronto Venture Exchange, nor its regulation services provider (as that term is defined in the policies of the exchange), accepts responsibility for the adequacy or accuracy of this release.

For more information, please contact:

David Wolf, President & CEO                    Michael Bruns, CFO
Hamilton Thorne Ltd.                                 Hamilton Thorne Ltd.
978-921-2050                                            978-921-2050
[email protected]                             [email protected]

Glen Akselrod
Bristol Investor Relations
905-326-1888
[email protected]